Newsfeeds - Spark Newswire

1 minute read

Events
News

Vaxcyte To Present At Guggenheimer Vaccine, Infectious Disease Conference Tuesday, Oct. 5, 2021 At 11:30 a.m. EDT

Today, 3:29 AM

Vaxcyte, Inc. (NASDAQ:PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious

PCVX

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:29 AM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday.

ABUS

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 3:29 AM

ACRX

3 minute read

34 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 3:29 AM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday.

ACRX

1 minute read

Vaxcyte Q2 EPS $(0.46) Up From $(1.72) YoY

By Benzinga Newsdesk

Today, 3:29 AM

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.46) per share. This is a 73.26 percent increase over losses of $(1.72) per share from the same period last year.

PCVX

2 minute read

Vaxcyte Reports Expansion Of Its CARB-X Award To Advance Development Of VAX-A1 To Prevent Group A Streptococcus Infections; Award Commits Added $3.2M In Funding, Total Potential Funding $29.7M Based On Milestones

By Benzinga Newsdesk

Today, 3:29 AM

-- Award Commits an Additional $3.2 Million in Funding; Total Potential Funding of $29.7 Million Based on Future Milestones -- -- Vaxcyte Plans to Initiate IND-Enabling Studies for VAX-A1 in Second

PCVX